
    
      Subjects will receive the following treatments in a crossover design:

      Treatment A (Reference): One 200 mg capsule of TR-701 di-sodium phosphate salt (equivalent to
      150 mg TR-700) administered orally after at least an 8-hour fast with 240 mL room temperature
      water;

      Treatment B (Test): One 182 mg capsule of TR-701 free acid phosphate (equivalent to 150 mg
      TR-700) administered orally after at least an 8-hour fast with 240 mL room temperature water;

      Descriptive statistics will be calculated for PK parameters including Cmax, Tmax, AUC0-t, and
      AUC0-inf.
    
  